Intervention Study of Face Mask and Hand Sanitizer to Reduce Influenza Transmission
NCT00490633 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1420
Last updated 2011-08-19
Summary
Pharmaceutical interventions, particularly vaccination, have been the principal public health method of preventing and controlling seasonal influenza. Other less invasive non-pharmaceutical interventions include the use of face masks and hand hygiene. In Asia, masks are used extensively, especially in Japan, but with only circumstantial evidence of efficacy. Although there are numerous studies that support hand hygiene as an effective measure for decreasing transmission of enteric infections, there are fewer data assessing the effect of hand hygiene on respiratory illnesses. Therefore it is proposed that a study be conducted on the use of face masks with and without the use of hand hygiene in comparison to no intervention in residence housing units of the University of Michigan. The interventions will be carried out during a period of influenza transmission that is defined by surveillance conducted at the University Health Service. Data will be collected on use of the interventions and the occurrence of influenza and other illnesses. When illness occurs meeting a case definition, specimens for viral isolation will be collected in all intervention settings. Face masks could theoretically lead to a large reduction in transmission frequency of influenza, especially if most transmission occurs by the airborne (large or small droplet) route. Even a modest reduction could have a major effect during an influenza pandemic.
Conditions
Interventions
- BEHAVIORAL
-
Ear Loop Procedure Mask
Facemasks were requested to be worn while participants were in the residence hall for year one, and while they were in residence halls for a minimum of six hours per day in year two.
- BEHAVIORAL
-
62% Ethyl Alcohol Hand Sanitizer
Hand sanitizer was provided to participants in the facemask and hand hygiene arm for year one and year two of the study.
Sponsors & Collaborators
-
Centers for Disease Control and Prevention
collaborator FED - lead OTHER
Principal Investigators
-
Arnold S Monto, MD · University of Michigan
-
Allison E Aiello, PhD · University of Michigan
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-10-31
- Primary Completion
- 2008-04-30
- Completion
- 2008-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Study of Exclusion Criteria in a University Population
NCT01472536 ·Status: COMPLETED ·Phase: NA
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
Project to Investigate Ways to Reduce the Spread of Influenza in Schools and Households With Children
NCT00446628 ·Status: COMPLETED ·Phase: NA
-
Evaluating Modes of Influenza Transmission
NCT01710111 ·Status: COMPLETED ·Phase: NA
-
Memory for Flu Facts and Myths and Effects on Vaccine Intentions
NCT00296270 ·Status: COMPLETED ·Phase: NA
-
Evaluating Modes of Influenza Transmission 2b Baseline SAR
NCT07342556 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluating Modes of Influenza Transmission Observational Study of Community Acquired Influenza
NCT01769430 ·Status: COMPLETED
-
Evaluation of Human Immune Responses to Influenza Virus Vaccination in Healthy Volunteers
NCT02385123 ·Status: TERMINATED ·Phase: PHASE4
-
DMID 21-0041; Influenza CVD 59000
NCT05666245 ·Status: COMPLETED ·Phase: NA
-
Immunologic Response to FluMist vs. Flucelvax
NCT03982069 ·Status: COMPLETED ·Phase: PHASE4
-
2009 H1N1 Pandemic and Seasonal Influenza in SCI/D: Infection Control Strategies
NCT01270685 ·Status: WITHDRAWN
-
Human Infection Study of H3N2 Influenza in Healthy Adults
NCT06972810 ·Status: COMPLETED ·Phase: NA
-
Dose, Safety, and Pathogenicity of a New Influenza A H3N2 Challenge Strain
NCT06613737 ·Status: COMPLETED ·Phase: NA
-
Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age
NCT00192140 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Herd Immunity and Influenza Vaccine Uptake
NCT03748160 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People
NCT06683352 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cluster RCT - Evaluating Effectiveness of a Guide and Tools for Influenza Immunization Campaign Planners
NCT01207518 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada
NCT01622491 ·Status: UNKNOWN
-
The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial
NCT02565277 ·Status: COMPLETED ·Phase: PHASE4
-
Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults
NCT01258842 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers
NCT02459171 ·Status: COMPLETED
-
Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine
NCT07232745 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4